IMMX
What one share of Immix Biopharma holds
Pharmaceutical Preparations
Immix Biopharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.83 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.82 |
| Cash and investments | $3.15 |
| Book value | $3.20 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$0.34 | — | −$0.12 | — | −$1.40 |
| 2021 | — | −$6.64 | $0.00 | −$0.43 | — | — |
| 2022 | — | −$0.59 | — | −$0.53 | — | $0.95 |
| 2023 | — | −$0.89 | $0.00 | −$0.66 | — | $0.82 |
| 2024 | — | −$0.76 | $0.04 | −$0.56 | — | $0.48 |
| 2025 | — | −$0.89 | $0.02 | −$0.75 | — | $1.77 |